961 CX-908, a PROBODY <sup>®</sup> T cell engager targeting CDH3 and CD3, induces tumor regressions and improves the therapeutic window in preclinical studies
20250 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 0.00
961 CX-908, a PROBODY <sup>®</sup> T cell engager targeting CDH3 and CD3, induces tumor regressions and improves the therapeutic window in preclinical studies | Researchclopedia